Advertisement
Research Article| Volume 22, ISSUE 10, P1264-1270, October 1987

Laboratory evaluation for cushing's syndrome in psychiatric patients with cortisol nonsuppression following the overnight dexamethasone suppression test

  • Thomas H. Lampe
    Correspondence
    Address reprint requests to Dr.T.H. Lampe, GRECC/182B, American Lake VA Medical Center, Tacoma, WA 98493.
    Affiliations
    From the Seattle/American Lake Veterans Administration Geriatric Research, Education and Clinical Center, Seattle, WAUSA

    the Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WAUSA
    Search for articles by this author
  • Bruce L. Fariss
    Affiliations
    the Department of Clinical Investigation, Madigan Army Medical Center, Tacoma, Seattle, WAUSA
    Search for articles by this author
  • Steven C. Risse
    Affiliations
    From the Seattle/American Lake Veterans Administration Geriatric Research, Education and Clinical Center, Seattle, WAUSA

    the Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WAUSA
    Search for articles by this author
  • Murray A. Raskind
    Affiliations
    From the Seattle/American Lake Veterans Administration Geriatric Research, Education and Clinical Center, Seattle, WAUSA

    the Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WAUSA
    Search for articles by this author
  • Stephen R. Plymate
    Affiliations
    the Department of Clinical Investigation, Madigan Army Medical Center, Tacoma, Seattle, WAUSA

    the Department of Medicine, University of Washington, Seattle, WAUSA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Laboratory tests used for the differential diagnosis of Cushing's syndrome have infrequently been employed in investigations of psychiatric patients who demonstrate hypothalamic-pituitary-adrenal (HPA) overactivity, and these laboratory procedures have not previously been applied for the specific purpose of further evaluating the endocrine function of psychiatric patients with serum cortisol nonsuppression following the standard 1-mg overnight Dexamethasone Suppression Test (DST). Low-dose (4 mg/48 hr) and high-dose (16 mg/48 hr) DSTs were administered to 10 psychiatric patients who exhibited cortisol nonsuppression after the overnight DST. Patients all had normal suppression to both the low-dose and high-dose tests. HPA overactivity in these patients was thus not sufficient to meet laboratory criteria for the diagnosis of Cushing's syndrome. Study results suggest that psychiatric patients with abnormal cortisol suppression following the 1-mg overnight DST are likely to have normal responses when assessed by standard laboratory protocols used for the diagnosis of Cushing's syndrome.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        APA, Washington, DC1980
        • Ashcraft MW
        • Van Herle AJ
        • Vener SL
        • Geffner DL
        Serum cortisol levels in Cushing's syndrome after low- and high-dose dexamethasone suppression.
        Ann Intern Med. 1982; 97: 21-26
        • Brown WA
        • Keither G
        • Quails CB
        • Haier R
        The Dexamethasone Suppression Test and pituitary adrenocortical function.
        Arch Gen Psychiatry. 1985; 42: 121-123
        • Butler PWP
        • Besser GM
        Pituitary-adrenal function in severe depressive illness.
        Lancet. 1968; 1: 1234-1236
        • Carroll BJ
        Dexamethasone Suppression Test: A review of contemporary confusion.
        J Clin Psychiatry. 1985; 46: 13-24
        • Carroll BJ
        • Curtis GC
        • Mendels J
        Neuroendocrine regulation in depression.I. Limbic system-adrenocortical dysfunction.
        Arch Gen Psychiatry. 1976; 33: 1039-1044
        • Carroll BJ
        • Curtis GC
        • Mendels J
        Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.
        Arch Gen Psychiatry. 1976; 33: 1051-1058
        • Carroll BJ
        • Feinberg M
        • Greden FJ
        • Tarika J
        • Albala AA
        • Haskett RF
        • James NM
        • Kronfol Z
        • Lohr N
        • Steiner M
        • de Vigne JP
        • Young E
        A specific laboratory test for the diagnosis of melancholia.
        Arch Gen Psychiatry. 1981; 38: 15-22
        • Gold PW
        Corticotropin-releasing factor stimulation in hypercortisolemic psychiatric states.
        (Chrousos GP (moderator))in: Clinical applications of corticotropin-releasing factor. Ann Intern Med. 102. 1985: 352-355
        • Gold PW
        • Chrousos G
        • Kellner C
        • Post R
        • Roy A
        • Augerinos P
        • Schulte H
        • Oldfield E
        • Loriaux DL
        Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
        Am J Psychiatry. 1984; 141: 619-627
        • Gold PW
        • Loriaux DL
        • Roy A
        • Kling MA
        • Calabrese JR
        • Kellner CH
        • Nieman LK
        • Post RM
        • Pickar D
        • Gallucci W
        • Avgerinos P
        • Paul S
        • Oldfield EH
        • Cutler GB
        • Chrousos GP
        Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease.
        N Engl J Med. 1986; 314: 1329-1335
        • Haskett RF
        Diagnostic categorization of psychiatric disturbance in Cushing's syndrome.
        Am J Psychiatry. 1985; 142: 911-916
        • Hirschfeld RMA
        • Koslow SH
        • Kupfer DJ
        The clinical utility of the Dexamethasone Suppression Test in psychiatry.
        JAMA. 1983; 250: 2172-2174
        • Krieger DT
        Rhythms of ACTH and corticosteroid secretion in health and disease, and their experimental modification.
        J Steroid Biochem. 1975; 6: 785-791
        • Liddle GW
        Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome.
        J Clin Endocrinol Metab. 1960; 20: 1539-1560
        • Pavlatos FC
        • Smilo RP
        • Forsham PH
        A rapid screening test for Cushing's syndrome.
        JAMA. 1965; 193: 96-99
        • Schlechte JA
        • Sherman B
        • Pfohl B
        A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease.
        Hormone Res. 1986; 23: 1-8
        • Stokes PE
        • Pick GR
        • Stoll PM
        • Nunn WD
        Pituitary adrenal function in depressed patients: resistance to dexamethasone suppression.
        J Psychiatr Res. 1975; 12: 271-281